Vedolizumab Study with Inflammatory Bowel Disease Patients in Germany
- Conditions
- K50K51Crohn disease [regional enteritis]Ulcerative colitis
- Registration Number
- DRKS00013251
- Lead Sponsor
- CED Service GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 1280
Inclusion Criteria
IBD-patients (UC/CD) aged 18-80 years at enrollment
- Written informed consent is given
Exclusion Criteria
Lack of adequate documentation possibilities
- Malignant disease in history
- Planned surgical intervention
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method